Anavex Life Sciences
AVXL
#7501
Rank
C$0.57 B
Marketcap
C$6.40
Share price
-4.28%
Change (1 day)
-53.87%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -C$65.86 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$70.18 Million a decrease over its 2023 earnings that were of -C$61.16 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$65.86 Million-6.17%
2024 -C$70.18 Million14.77%
2023 -C$61.16 Million-17.49%
2022 -C$74.12 Million22.96%
2021 -C$60.28 Million35.36%
2020 -C$44.53 Million12.65%
2019 -C$39.53 Million29.09%
2018 -C$30.62 Million36.33%
2017 -C$22.46 Million17.11%
2016 -C$19.18 Million20.91%
2015 -C$15.87 Million-6.29%
2014 -C$16.93 Million337.28%
2013 -C$3.88 Million
2008 -C$7.16 Million106.01%
2007 -C$3.48 Million8848.98%
2006 -C$0.04 Million-79.99%
2005 -C$0.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
C$90.92 M-242.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
C$89.26 M-240.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-C$6.53 Million-89.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-C$9.01 Million-85.86%๐Ÿ‡บ๐Ÿ‡ธ USA